Literature DB >> 32454978

Miliary lung metastases from ROS1-rearranged lung adenocarcinoma: A case report.

Ryota Otoshi1, Akimasa Sekine1, Koji Okudela2, Takuma Katano1, Masato Asaoka1, Satoshi Ikeda1, Tomohisa Baba1, Shigeru Komatsu1, Eri Hagiwara1, Ogura Takashi1.   

Abstract

Miliary lung metastases are a rare form of metastasis of non-small-cell lung carcinoma. Miliary lung metastases commonly develop in lung adenocarcinoma with epidermal growth factor receptor mutation. In the present study, we present a case of miliary lung metastases from lung adenocarcinoma with ROS1 rearrangement. The patient, who had a history of surgery for stage IIIA lung adenocarcinoma, presented to our hospital with cough, dyspnea, and severe hypoxia. Chest computed tomography showed numerous tiny, randomly distributed nodules throughout both lungs. No metastases were observed in other organs. Molecular profiling of the surgical specimens was positive for ROS1 rearrangement. The results suggest that chest physicians should be aware that miliary lung metastases can develop in patients with lung adenocarcinoma with ROS1 rearrangement.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  ROS1; adenocarcinoma; miliary metastases; non-small cell

Year:  2020        PMID: 32454978      PMCID: PMC7241238          DOI: 10.3892/mco.2020.2040

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  9 in total

1.  Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Authors:  Alice T Shaw; Sai-Hong I Ou; Yung-Jue Bang; D Ross Camidge; Benjamin J Solomon; Ravi Salgia; Gregory J Riely; Marileila Varella-Garcia; Geoffrey I Shapiro; Daniel B Costa; Robert C Doebele; Long Phi Le; Zongli Zheng; Weiwei Tan; Patricia Stephenson; S Martin Shreeve; Lesley M Tye; James G Christensen; Keith D Wilner; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2014-09-27       Impact factor: 91.245

2.  [ROS-1 rearranged bronchopulmonary adenocarcinoma revealed by a pulmonary miliary].

Authors:  Aurélien Brindel; Dimitri Huet; Pierre Vaillant; Jean-Michel Vignaud; Angelica Tiotiu
Journal:  Bull Cancer       Date:  2018-04-27       Impact factor: 1.276

3.  Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

Authors:  Yi-Long Wu; James Chih-Hsin Yang; Dong-Wan Kim; Shun Lu; Jianying Zhou; Takashi Seto; Jin-Ji Yang; Noboru Yamamoto; Myung-Ju Ahn; Toshiaki Takahashi; Takeharu Yamanaka; Allison Kemner; Debasish Roychowdhury; Jolanda Paolini; Tiziana Usari; Keith D Wilner; Koichi Goto
Journal:  J Clin Oncol       Date:  2018-03-29       Impact factor: 44.544

4.  Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.

Authors:  Eckart Laack; Ronald Simon; Marc Regier; Birte Andritzky; Pierre Tennstedt; Christian Habermann; Christoph Zur Verth; Ina Thöm; Tobias Grob; Guido Sauter; Carsten Bokemeyer
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

5.  Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.

Authors:  Fred Hsu; Alan Nichol; Ted Toriumi; Alex De Caluwe
Journal:  Acta Oncol       Date:  2017-05-19       Impact factor: 4.089

6.  Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: a case report.

Authors:  Alexander T Falk; Michel Poudenx; Josiane Otto; Hannah Ghalloussi; Jérôme Barrière
Journal:  Lung Cancer       Date:  2012-09-19       Impact factor: 5.705

Review 7.  Crizotinib in the treatment of non--small-cell lung cancer.

Authors:  Sacha I Rothschild; Oliver Gautschi
Journal:  Clin Lung Cancer       Date:  2013-06-20       Impact factor: 4.785

8.  Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis.

Authors:  Shang-Gin Wu; Fu-Chang Hu; Yih-Leong Chang; Yung-Chie Lee; Chong-Jen Yu; Yeun-Chung Chang; Jenn-Yu Wu; Jin-Yuan Shih; Pan-Chyr Yang
Journal:  Eur Respir J       Date:  2012-04-20       Impact factor: 16.671

9.  Association of miliary lung metastases and bone metastases in bronchogenic carcinoma.

Authors:  S Umeki
Journal:  Chest       Date:  1993-09       Impact factor: 9.410

  9 in total
  2 in total

Review 1.  ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date.

Authors:  Sébastien Gendarme; Olivier Bylicki; Christos Chouaid; Florian Guisier
Journal:  Curr Oncol       Date:  2022-01-28       Impact factor: 3.677

2.  Artificial Intelligence System Application in Miliary Lung Metastasis: Experience from a Rare Case.

Authors:  Yu Zhang; Yan Chen; Kun Li; Wen Jiang; Bi-Cheng Zhang
Journal:  Risk Manag Healthc Policy       Date:  2021-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.